Evidence map›Paper›PMID 32560563›Full record

ArticleInternational journal of molecular sciences2020

Purified Tea (

Ning Ren, Lianfu Chen, Bo Li, Gary O Rankin, Yi Charlie Chen, Youying Tu

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.4field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Article
  3. Long non-coding RNAJournal of thoracic disease · 2023
    Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 2 countries.

Ning RenDepartment of Tea Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.ORCID 0000-0003-2104-6158
Lianfu ChenDepartment of Tea Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Bo LiDepartment of Tea Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.ORCID 0000-0002-7294-6888
Gary O RankinDepartment of Biomedical Sciences, Joan C. Edwards School of Medicine, Marshall University, Huntington, WV 25755, USA.
Yi Charlie ChenCollege of Health, Science, Technology and Mathematics, Alderson Broaddus University, 101 College Hill Drive, Philippi, WV 26416, USA.ORCID 0000-0001-6865-9512
Youying TuDepartment of Tea Science, Zhejiang University, 866 Yuhangtang Road, Hangzhou 310058, China.
Alderson Broaddus University · USZhejiang University · CNMarshall University · US

Funding

West Virginia IDEA-CTRU54GM104942 · NIGMS · WEST VIRGINIA UNIVERSITY · PI JUDITH FEINBERG · 2012 to 2026
$81.0M
WV INBRE: The Inhibitor of Growth Family Member 4 (ING4) inhibits L-Type Amino Acid Transporter 1 (LAT1) expression to suppress Breast CancerP20GM103434 · NIGMS · MARSHALL UNIVERSITY · PI GARY O RANKIN · 2012 to 2026
$61.1M
WVU &MU NEW FACULTY GRANTSP20RR016477 · NCRR · MARSHALL UNIVERSITY · PI RANKIN, GARY O · 2001 to 2011
$35.5M
Center of Research Excellence in Natural Products Neuroscience (CORE-NPN)P20GM104932 · NIGMS · UNIVERSITY OF MISSISSIPPI · PI MAJUMDAR, SOUMYAJIT · 2012 to 2016
$10.0M
ARIA S10 RR020866COBRE GM102488/RR032138FORTESSA S10 OD016165Key Research and Development Projects in Zhejiang Province 2018C02012National Institute for General Medical Sciences P20GM103434National Institute for General Medical Sciences P20GM104932National Key Research and Development Plan 2017YFD0400803National Natural Science Foundation of China Grant 31501474NCRR NIH HHS P20RR016477NIGMS NIH HHS U54 GM104942OD016165 GM103434
6 · The paper itself

Abstract

Ovarian cancer is currently ranked at fifth in cancer deaths among women. Patients who have undergone cisplatin-based chemotherapy can experience adverse effects or become resistant to treatment, which is a major impediment for ovarian cancer treatment. Natural products from plants have drawn great attention in the fight against cancer recently. In this trial, purified tea (

Indexed as

Drug Resistance, NeoplasmApoptosisCell Line, TumorCell ProliferationCell SurvivalCisplatinDNA DamageFemaleFlowersHumansMass SpectrometryMolecular StructureOvarian NeoplasmsSaponinsSignal TransductionTeaCisplatinSaponinsTeaTP53 protein, humanTumor Suppressor Protein p53Chakasaponin Iintrinsic apoptosisovarian cancerp53 pathwaytea flower saponins

Identifiers

PMID32560563
PMCPMC7352341
OpenAlexW3036374191

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.